We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Avg Time Held
6
years
Top 10 Avg Time Held
5.4
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Arlo Technologies
ARLO
$1.34B
| $51.2M | 0.04% |
4,696,910
-143,550
| -3% | -$1.17M |
2018 Q3
19 quarters
|
|
177
Norwegian Cruise Line
NCLH
$7.07B
| $50.6M | 0.04% |
2,324,970
-78,600
| -3% | -$1.2M |
2014 Q1
37 quarters
|
|
178
L3Harris
LHX
$44.8B
| $49.2M | 0.04% |
251,300
| – | – |
2020 Q1
13 quarters
|
|
179
Trade Desk
TTD
$6.21B
| $49.2M | 0.04% |
637,000
-130,800
| -17% | -$8.85M |
2023 Q1
1 quarter
|
|
180
Altria Group
MO
$123B
| $49M | 0.04% |
1,080,800
-37,900
| -3% | -$1.72M |
2017 Q2
24 quarters
|
|
181
SLB Ltd
SLB
$71.8B
| $47.4M | 0.04% |
965,000
+6,000
| +0.6% | +$286K |
2013 Q2
40 quarters
|
|
182
Nextpower Inc. Common Stock
NXT
$12.7B
| $46.6M | 0.04% |
1,169,690
-59,710
| -5% | -$2.19M |
2023 Q1
1 quarter
|
|
183
Honeywell
HON
$66.7B
| $45.9M | 0.04% |
234,736
-7,490
| -3% | -$1.39M |
2013 Q2
40 quarters
|
|
184
DELISTED
Exact Sciences
EXAS
| $45M | 0.04% |
479,300
| – | – |
2014 Q2
36 quarters
|
|
185
Cameco
CCJ
$36.2B
| $45M | 0.04% |
1,435,500
+15,700
| +1% | +$442K |
2019 Q2
16 quarters
|
|
186
nVent Electric
NVT
$23.6B
| $44.4M | 0.04% |
860,000
-20,400
| -2% | -$906K |
2018 Q2
20 quarters
|
|
187
Glaukos
GKOS
$9.77B
| $44M | 0.04% |
618,500
+10,300
| +2% | +$591K |
2017 Q4
22 quarters
|
|
188
JetBlue
JBLU
$1.19B
| $44M | 0.04% |
4,965,800
-144,600
| -3% | -$1.05M |
2013 Q2
40 quarters
|
|
189
XPO
XPO
$22.1B
| $43.1M | 0.04% |
729,900
+4,600
| +0.6% | +$208K |
2021 Q1
9 quarters
|
|
190
Okta
OKTA
$36.5B
| $43M | 0.04% |
620,666
+42,800
| +7% | +$3.25M |
2020 Q1
13 quarters
|
|
191
Marvell Technology
MRVL
$217B
| $42.4M | 0.04% |
709,300
+218,400
| +44% | +$10.6M |
2023 Q1
1 quarter
|
|
192
Victoria's Secret
VSXY
$7.22B
| $42M | 0.04% |
2,408,839
-23,866
| -1% | -$601K |
2021 Q3
7 quarters
|
|
193
Deere & Co
DE
$175B
| $40.7M | 0.03% |
100,350
-37,800
| -27% | -$14.5M |
2013 Q2
40 quarters
|
|
194
Newell Brands
NWL
$2.46B
| $40.3M | 0.03% |
4,636,500
+696,700
| +18% | +$6.93M |
2014 Q1
37 quarters
|
|
195
RTX Corp
RTX
$252B
| $39.5M | 0.03% |
403,432
-10,600
| -3% | -$1.04M |
2013 Q4
38 quarters
|
|
196
GFL Environmental
GFL
$19B
| $37.2M | 0.03% |
960,000
+22,500
| +2% | +$818K |
2022 Q4
2 quarters
|
|
197
Neurocrine Biosciences
NBIX
$13.9B
| $37.1M | 0.03% |
393,360
+21,620
| +6% | +$2.11M |
2022 Q4
2 quarters
|
|
198
Kyntra Bio
KYNB
$21.7M
| $36.9M | 0.03% |
547,104
-17,964
| -3% | -$7.43M |
2019 Q4
14 quarters
|
|
199
DELISTED
Altair Engineering Inc
ALTR
| $36.5M | 0.03% |
480,950
-58,500
| -11% | -$4.18M |
2017 Q4
22 quarters
|
|
200
MGM Resorts International
MGM
$7.42B
| $36M | 0.03% |
820,600
-13,010
| -2% | -$556K |
2016 Q3
27 quarters
|
|
Similar funds
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.